Yüklüyor......
Current and emerging immunotherapeutic approaches to the treatment of multiple myeloma
Multiple myeloma (MM) has a worldwide incidence of 1–5/100,000/year. Outcomes have improved significantly in recent years following incorporation of immunomodulatory drugs and proteasome inhibitors into standard-of-care regimes. MM is profoundly immunosuppressive, enabling immune evasion, proliferat...
Kaydedildi:
| Yayımlandı: | Ther Adv Hematol |
|---|---|
| Asıl Yazarlar: | , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
SAGE Publications
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6582283/ https://ncbi.nlm.nih.gov/pubmed/31244984 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040620719854171 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|